Literature DB >> 30669938

Salivary IgA to MAA-LDL and Oral Pathogens Are Linked to Coronary Disease.

R Akhi1,2,3, C Wang1,2,3, A E Nissinen1,2,3, J Kankaanpää1,2,3, R Bloigu4, S Paju5, P Mäntylä5,6,7, K Buhlin5,8, J Sinisalo9, P J Pussinen5, S Hörkkö1,2,3.   

Abstract

A large body of literature has established the link between periodontal disease and cardiovascular disease. Oxidized low-density lipoproteins (OxLDLs) have a crucial role in atherosclerosis progression through initiation of immunological response. Monoclonal IgM antibodies to malondialdehyde-modified low-density lipoprotein (MDA-LDL) and to malondialdehyde acetaldehyde-modified low-density lipoprotein (MAA-LDL) have been shown to cross-react with the key virulence factors of periodontal pathogens Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. We have previously shown that salivary IgA antibodies to MAA-LDL cross-react with P. gingivalis in healthy humans. In this study, we aim to assess whether oral mucosal immune response represented by salivary IgA to MAA-LDL and oral pathogens is associated with coronary artery disease (CAD). Also, the molecular mimicry through antibody cross-reaction between salivary IgA to MAA-LDL and oral pathogens was evaluated. The study subjects consisted of 451 patients who underwent a coronary angiography with no CAD ( n = 133), stable CAD ( n = 169), and acute coronary syndrome (ACS, n = 149). Elevated salivary IgA antibody levels to MAA-LDL, Rgp44 (gingipain A hemagglutinin domain of P. gingivalis), and Aa-HSP60 (heat shock protein 60 of A. actinomycetemcomitans) were discovered in stable-CAD and ACS patients when compared to no-CAD patients. In a multinomial regression model adjusted for known cardiovascular risk factors, stable CAD and ACS were associated with IgA to MAA-LDL ( P = 0.016, P = 0.043), Rgp44 ( P = 0.012, P = 0.004), Aa-HSP60 ( P = 0.032, P = 0.030), Tannerella forsythia ( P = 0.002, P = 0.004), Porphyromonas endodontalis ( P = 0.016, P = 0.020), Prevotella intermedia ( P = 0.038, P = 0.005), and with total IgA antibody concentration ( P = 0.002, P = 0.016). Salivary IgA to MAA-LDL showed cross-reactivity with the oral pathogens tested in the study patients. The study highlights an association between salivary IgA to MAA-LDL and atherosclerosis. However, whether salivary IgA to MAA-LDL and the related oral humoral responses play a causal role in the development in the CAD should be elucidated in the future.

Entities:  

Keywords:  atherosclerosis; bacterial virulence; biomarkers; lipids; mucosal immunity; periodontal disease(s)/periodontitis

Year:  2019        PMID: 30669938     DOI: 10.1177/0022034518818445

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  4 in total

1.  Existence of natural mouse IgG mAbs recognising epitopes shared by malondialdehyde acetaldehyde adducts and Porphyromonas gingivalis.

Authors:  Mikael Kyrklund; Heidi Kaski; Ramin Akhi; Antti E Nissinen; Outi Kummu; Ulrich Bergmann; Pirkko Pussinen; Sohvi Hörkkö; Chunguang Wang
Journal:  Innate Immun       Date:  2021-01-14       Impact factor: 2.680

2.  Systemic Antibiotics Influence Periodontal Parameters and Oral Microbiota, But Not Serological Markers.

Authors:  Elisa Kopra; Laura Lahdentausta; Milla Pietiäinen; Kåre Buhlin; Päivi Mäntylä; Sohvi Hörkkö; Rutger Persson; Susanna Paju; Juha Sinisalo; Aino Salminen; Pirkko J Pussinen
Journal:  Front Cell Infect Microbiol       Date:  2021-12-24       Impact factor: 5.293

Review 3.  Heat shock protein 60 and cardiovascular diseases: An intricate love-hate story.

Authors:  Indumathi Krishnan-Sivadoss; Iván A Mijares-Rojas; Ramiro A Villarreal-Leal; Guillermo Torre-Amione; Anne A Knowlton; C Enrique Guerrero-Beltrán
Journal:  Med Res Rev       Date:  2020-08-17       Impact factor: 12.388

4.  Association among serum and salivary A. actinomycetemcomitans specific immunoglobulin antibodies and periodontitis.

Authors:  Gaetano Isola; Alessandro Polizzi; Romeo Patini; Sebastiano Ferlito; Angela Alibrandi; Giuseppe Palazzo
Journal:  BMC Oral Health       Date:  2020-10-15       Impact factor: 2.757

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.